CRMDCorMedix Inc.

$518M

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7,551-94.5% YoY

Gross Profit

-$26,112-345.8% margin

Operating Income

-$9M-113523.4% margin

Net Income

-$9M-113321.6% margin

EPS (Diluted)

$-0.52

QoQ Revenue Growth

-67.5%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$358,175

Balance Sheet

Total Assets

$6M

Total Liabilities

$12M

Stockholders' Equity

-$6M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7,551	$136,168	-94.5%
Gross Profit	-$26,112	$118,116	-122.1%
Operating Income	-$9M	-$7M	-22.1%
Net Income	-$9M	-$5M	-66.3%

CRMD Q2 2018 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena